在心力衰竭患者中,心室节拍负荷和左心室功能之间的相关性,心脏衰竭患者的排气分数减少
Timothy G Scully1, Tenzin Kelsang1, Brendan Backhouse1
1Department of Cardiology, Eastern Health, Box Hill Hospital, Box Hill, Victoria, Australia.
Journal of cardiovascular electrophysiology
|December 15, 2023
概括
在带有起器的心力衰竭患者中,高右心室节奏负担不会使左心室功能恶化. 已确定的心脏起器诱导心肌病的风险因素在这个人群中没有预测力.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 心脏衰竭管理的管理
背景情况:
- 心脏起器诱导的心肌病与心室节拍负担有关,这些患者有保存的喷射分数.
- 右上心室节奏对先前存在左心室功能抑郁的患者的影响尚不清楚.
研究的目的:
- 为了研究右心室节奏百分比与左心室射出分数随时间变化之间的关系.
- 为了确定心脏起器诱导心肌病的确定的风险因素是否适用于基线心力衰竭的患者.
主要方法:
- 对带有单或双起器和基线射出分数<50%的患者的分析.
- 不包括双心脏器械.
- 主要终点:心室节奏百分比与左心室喷射率变化之间的相关性.
主要成果:
- 在58名患者中,室内节奏的程度和左室功能绝对变化 (r = .04,p = .979) 之间没有显著的相关性.
- 之前确定了心脏起器诱导心肌病的危险因素,但没有预测该队列中喷射分数的显著下降.
结论:
- 右心室节奏的程度和其他已知的心脏起器诱导心肌病的风险因素似乎不会在患有先前心力衰竭的患者中构成相同的风险.
- 这些发现表明,对患者和没有基线左心室功能障碍的患者来说,节奏策略可能会有所不同.
更多相关视频
08:21Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
Published on: June 15, 2020
4.2K
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.5K
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594
Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
Pathophysiology of Cardiac Performance
672
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
672
